Tyrosine News and Research

RSS
Novel Amino Acid Nanoparticles Offer Hope for Fighting Multi-Drug Resistant Cancers

Novel Amino Acid Nanoparticles Offer Hope for Fighting Multi-Drug Resistant Cancers

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

New Irreversible Inhibitor Overcomes Drug Resistance in Cancer Cells

Novel Activation Mechanism for First Identified Oncogene

Novel Activation Mechanism for First Identified Oncogene

Live Broadcasting of “Growth Factor Signaling” Proteins Inside Living Cells

Live Broadcasting of “Growth Factor Signaling” Proteins Inside Living Cells

New Genome Editing Technology Achieves Precise Targeted Insertion of DNA Segments

New Genome Editing Technology Achieves Precise Targeted Insertion of DNA Segments

The Role of Siglec-14 Receptors on Human Macrophages in CNT Recognition in Humans

The Role of Siglec-14 Receptors on Human Macrophages in CNT Recognition in Humans

Study explains why cancers stop responding to kinase inhibitors and come back stronger

Study explains why cancers stop responding to kinase inhibitors and come back stronger

New gene helps drive the development of the common lung cancer type

New gene helps drive the development of the common lung cancer type

Revealing the mechanism that ensures genome stability in normal cells

Revealing the mechanism that ensures genome stability in normal cells

A new outlook on sow breeding using dietary nucleotides

A new outlook on sow breeding using dietary nucleotides

Delicate strategy employed by pathogens to suppress pyroptosis

Delicate strategy employed by pathogens to suppress pyroptosis

Researchers discover effective therapy for pediatric T-acute leukemia

Researchers discover effective therapy for pediatric T-acute leukemia

Researchers developed a weapon to combat drug-resistant malaria

Researchers developed a weapon to combat drug-resistant malaria

Epigenetic regulator helps determine lung cancer patients and their resistance to drugs

Epigenetic regulator helps determine lung cancer patients and their resistance to drugs

Discovery of chiral evasion could lead to more resilient inhibitors, better drug designs

Discovery of chiral evasion could lead to more resilient inhibitors, better drug designs

Targeting Shp2 as a cancer therapy may worsen the disease

Targeting Shp2 as a cancer therapy may worsen the disease

Research uncovers key component of cellular malfunction that contributes to tumor growth

Research uncovers key component of cellular malfunction that contributes to tumor growth

Targeted drug shows promise against brain metastases from kidney cancer

Targeted drug shows promise against brain metastases from kidney cancer

Research reveals involvement of secretory granules in Parkinson’s disease

Research reveals involvement of secretory granules in Parkinson’s disease

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.